Objective Evaluating sexual function and quality of life (QoL) Results Twelve months after surgery, 29 patients were engaging in regular sexual activity. The FSFI test results showed a satisfactory sexual function compared to the general population, with median values of 25.85 (range 4.6-30.5) at 12 months, 27.2 (range 4.4-33.6) at 36 months, and 29.6 (range 23.9-33.6) at 60 months. The PGWBI questionnaire showed a median score of 420.5 (range 108-540) before surgery, and 459 (range 252-533) at the 60-month follow-up.
Introduction
Mayer-Rokitansky-K€ uster-Hauser syndrome (MRKHS) is the most common form of vaginal agenesis and the second most common cause of primary amenorrhea; the incidence has been estimated as 1 in 4500 female births. [1] [2] [3] [4] This syndrome is subdivided in two types: type I (isolated) or Rokitansky sequence, reported in the Online Mendelian Inheritance in Man (OMIM) database as OMIM 277000, in which only the caudal part of the M€ uller duct is anomalous, and type II or M€ ullerian duct aplasia, Renal dysplasia, and Cervical Somite anomalies (MURCS) association (OMIM 601076), often associated with other malformations involving the upper urinary tract, the skeleton, and the otologic sphere; heart malformations can occur, but they are rare. 5, 6, 7 Therefore, a correct diagnosis of M€ ullerian agenesis includes investigations to identify the main features, to help frame the typical defects and any associated malformations.
The primary endpoint of the treatment of vaginal agenesis is to allow women to have a satisfactory sexual life. Accordingly, the ideal treatment should aim to achieve an anatomically and functionally appropriate neovagina. The goal of any method is to create a vaginal canal of adequate diameter and length, and appropriate axis to accommodate sexual intercourse. It should also have appropriate location, posterosuperior direction, suitable size, hairless walls, and it should be coated with elastic tissue and a layer of mucosa. In addition, the vagina should have normal amounts of secretion and lubrication and should require minimal care for maintenance. 9 The literature describes various methods for the treatment of MRKHS, each with advantages and disadvantages. In 2006, our group developed a new technique for the treatment of M€ ullerian agenesis, modifying the Abb e-McIndoe surgical procedure using in vitro cultivated autologous vaginal tissue to cover the walls of a neovagina surgically created in the space between rectum and bladder. 7 The intervention of vaginoplasty is an opportunity to achieve a normal sex life, and this has a major impact on quality of life (QoL). The most important parameter to consider in order to confirm the anatomical success of the intervention during the follow-up period is patient sexual satisfaction, which is directly proportional to the treatment's success.
The aim of this study is the evaluation of the long-term sexual function and QoL in patients treated with the modified Abb e-McIndoe technique with the use of in vitro cultured autologous vaginal mucosa.
Patients and methods
Between 2006 and 2016, 39 Caucasian women with MRKH syndrome were referred to our institution. All patients exhibited primary amenorrhea, normal secondary sexual characteristics, and a vaginal dimple without vaginal orifice. All women underwent a pre-operative work-up, which included trans-abdominal ultrasound scan, chromosome analysis, abdominopelvic MRI, ECG, echocardiogram and chest X-ray. It was crucial to assess each patient's motivation and desire to undergo the operation as the success of the procedure is greatly influenced in the post-surgery phase by the patient's continued use of the dilators needed to ensure the patency of the neovagina. The patients selected for surgery were those who expressed the need to begin to lead a normal sexual life and express their womanhood in a complete manner.
Patients who could be treated by the Frank conservative method, patients with uncertain diagnosis of MRKHS, and patients without suitable and sufficient vaginal tissue were excluded. Similarly, the surgery is not recommended in cases with alterations in coagulation processes and tissue repair.
Each patient with MRKHS was subjected to a full-thickness mucosal biopsy from the vaginal vestibule. After enzymatic dissociation, cells were inoculated onto collagen IV (10 mg/dl) coated plates and cultured for 2-3 weeks (Appendix S1). The patients were subjected to vaginoplasty with a modified Abb e-McIndoe technique using autologous in vitro cultured vaginal tissue, as previously reported. 10 Patients underwent clinical follow-up visits at 1, 3, 6, and 12 months after surgery, and every year thereafter. Clinical follow-up included vaginal examination and vaginoscopy. Both vaginal cytology and vaginal biopsy were obtained at the 3-month follow-up visit.
At 6 months, this procedure can be declared a success if the neovagina has not undergone any shrinkage, does not give off unpleasant smells, does not cause vaginal dryness, and presents a normal vaginal flora. 10 To quantify QoL and sexual satisfaction, two questionnaires, both validated and in the Italian language, the Female Sexual Function Index (FSFI) and the Psychological General Well Being Index (PGWBI), were administered to each patient.
Functional results were assessed using the FSFI questionnaire at 12, 36, and 60 months after surgery. The FSFI, a 19-item questionnaire, has been developed as a brief, multidimensional, self-reported instrument for assessing sexual function in women. Based on factor analytic methods, six factors or domains of sexual function were identified: (i) desire, (ii) subjective arousal, (iii) lubrication, (iv) orgasm, (v) satisfaction, and (vi) pain/discomfort. A scoring system was developed for obtaining individual domain scores and a total score. A total score of 26.55 is the cut-off proposed to assess sexual function, as lower values indicate an impairment in sexual function. The highest total FSFI score that may be obtained is 36. The mean score in the normal population is 30, so a good functional result can be considered when the total score ranges between 30 and 36, satisfactory between 23 and 29, and poor when 23 or less.
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A questionnaire for the assessment of QoL was administered to each patient before the intervention and again at 6 and 36 months after surgery,. The choice of this questionnaire is related to its extreme rigour, its high reproducibility and internal consistency, and the meticulous methodological framework that supports it. 12 The original PGWBI consists of 22 self-administered items, rated on a 6-point scale, that assess psychological and general wellbeing of respondents in six health-related QoL domains: anxiety, depressed mood, positive well-being, self-control, general health and vitality. Each item is rated with a numerical value ranging from 100 (perfect health) to 0 (worst standard of health). The total scores derived from each domain give an overall score that expresses the degree of psychological and emotional well-being and that is correlated with the general population of the same sex and similar age (median standardized profile).
Results
The operation was performed successfully in all 39 patients. Patient characteristics are presented in Table 1 . The mean age of patients at surgery was 18.5 years (range 16-49 years). Twenty-two patients (56%) were affected by MRKHS type I, 17 patients (44%) had type II. Fourteen patients (36%) had two non-functioning rudimentary emiuteri; 12 patients (31%) had complete agenesis of the uterus and the fallopian tubes; 10 (26%) patients had a single hypoplastic uterus; and 3 (8%) had a functioning hypoplastic uterus, causing cyclical pelvic pain, and were treated with estrogen-progestin therapy. Renal abnormalities were present in 10 patients (26%), congenital heart defect in 3 patients (8%), skeletal malformations in 3 patients (8%), and 4 patients (10%) had abnormal hearing. All patients tolerated the procedure well and there were no intraoperative complications.
The surgical data are presented in Table 2 . The size of the vaginal biopsy ranged from 0.5 to 2 cm² (mean 1 cm²). The period between the biopsy and the development of the fully differentiated mucosal tissue ranged from 15 to 36 days (mean time 21 days). The mean operative time was 23 minutes (range 15-60 minutes), and mean blood loss was 85 ml (range 20-110 ml). Post-operatively, all the patients were placed on a liquid diet until day 3, and a Foley bladder catheter was maintained to avoid contamination of the surgical site by urine and faeces. After the first surgical medication, the Foley was removed and all patients were instructed to perform bladder training. No postoperative complications were reported. The length of hospitalization ranged from 2 to 16 days. The vaginal tissue percentage of attachment, pointed out during the first post-operative examination of the neovagina, was satisfactory at between 50 and 100% (mean 80%). Patients started using the dilators autonomously after a mean post-operative time of 11 days (range 3-16 days).
As anatomical result, the median length of the vaginal canal was 8 cm (range 6-12) with a width of 2 cm. These dimensions were found unchanged when followed-up at 12 months. Cytology and biopsy histology performed at 3 months showed a normal vaginal mucosa with no signs of atrophy.
One year after surgery, 29 patients had resumed regular sexual activity. They completed the FSFI questionnaire and the results were encouraging: a median score of 25.85 (range 4.6-30.5). The second follow-up was performed for 21 patients, with the FSFI questionnaire showing a median score of 27.2 (range 4.4-33.6). The third administration of the FSFI questionnaire to 18 patients confirmed the expected results, with a median score of 29.6 (range 23.9-33.6). Before surgical treatment, patients also completed the PGWBI questionnaire, which showed a median total score of 420.5 (range 108-540). The same questionnaire was also completed at the last follow-up, showing a median total score increase to 459 (range 252-533). At the time of data cut-off, 18 patients had reached the 60 months' follow-up for the third administration of the FSFI questionnaire, and 15 patients had reached the third administration of the PGWBI questionnaire. There was no loss to followup patients. Patients underwent surgery, and the administration of the questionnaires was performed at the relevant follow-up times for each patient. FSFI and PGWBI questionnaire results are shown in Table 3 . 
Discussion

Main findings
In the last century, various therapeutic approaches have been proposed to treat vaginal agenesis, each one with advantages and disadvantages. From the first description by Abb e, 13 many changes have been introduced to the technique, the most significant ones concerning the lining material of the newly formed canal. In our experience with the modified Abb e-McIndoe's surgery, using autologous in vitro cultured vaginal tissue, the graft is autologous and orthotopic, with no risk of rejection from the recipient site. The procedure is fast and does not leave scars. The major disadvantage of this technique is the cellular therapy component, which means it can only be performed in specialized centres with a cell factory that meets good manufacturing practice (GMP) requirements, and that it is necessary to coordinate the availability of the operating room with the needs of the laboratory when the tissue is ready to be transplanted.
Strengths and limitations
Since 2006, there has been a refinement of our surgical technique. The operative times and intraoperative blood losses have decreased. We have also improved the postoperative management, shortening the length of stay, making the patients self-sustaining at home in less time with regard to the use of vaginal dilators. The use of vaginal mucosa grown in vitro is still a new technique, but our reported data show the use of autologous tissue grown in vitro is feasible and safe for patients affected by the MRKHS. The re-epithelialization is rapid because of the autologous material, and there is a chance to get enough tissue to cover the whole vaginal canal. In addition, after the removal of the gauzes and the vaginal dilator (kept in place to further press the newly formed vaginal tissue against the vaginal wall), epithelialization may be noted for the entire length of the vaginal walls. This suggests that the epithelialization comes from the transplanted tissue and not, as in other techniques, from the vaginal vestibule tissue. Additionally, a recently published study extensively describes the characteristic of vaginal mucous grown in vitro, proving the epithelial characteristics and the existence of mucinous glands between the grown cells that give a normal glandular function to the new vagina. Furthermore, to the patient, the idea of having a new vagina consisting of her own vaginal tissue plays a significant role, psychologically and emotionally, in having a normal sex life.
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Interpretation
The main objective of this procedure is assuring good sexual function. Our results, obtained through the administration of the FSFI, show satisfactory sexual activity that is maintained and improves over time. Furthermore, this technique has a beneficial impact on the patient's QoL, with a higher psychological-emotional state PGWBI score compared with that at admission and in terms of the median standardized profile of the general population of the same sex and age. Moreover, the awareness of a patient that the neovagina consists of vaginal tissue plays an important role with regard to the improved psychologicalemotional status that contributes to achieving a regular sexual life, which remains the first true endpoint of vaginal agenesis treatment. Our results suggest that the intervention of vaginoplasty with autologous vaginal tissue improves QoL besides ensuring a satisfying sex life.
Conclusion
In conclusion, we have shown that vaginal autologous tissue grown in vitro is the ideal material for vaginoplasty in patients with MRKHS. This technique is innovative, the treated patients stop being 'different', 'sick', and 'lacking something', and develop a positive self-perception that persists over time.
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